These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1665700)

  • 21. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.
    Van Maanen C; Terpstra C
    Biologicals; 1990 Oct; 18(4):315-9. PubMed ID: 2178351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The differentiation of foot and mouth disease virus strains using an indirect sandwich enzyme-linked immunosorbent assay saturation model.
    Ouldridge EJ; Barnett PV; Hingley PJ; Rweyemamu MM
    J Biol Stand; 1984 Oct; 12(4):367-77. PubMed ID: 6098582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.
    Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E
    Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of inactivated foot-and-mouth disease virus antigen in liquid-phase blocking ELISA.
    Ferris NP; Kitching RP; Oxtoby JM; Philpot RM; Rendle R
    J Virol Methods; 1990 Jul; 29(1):33-41. PubMed ID: 2170435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
    Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of foot-and-mouth disease virus by monoclonal antibodies.
    Alonso A; Gomes MD; Ramalho AK; Allende R; Barahona H; Söndahl MS; Osorio FA
    Viral Immunol; 1993; 6(3):219-28. PubMed ID: 7507329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.
    Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N
    Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and standardization of a piezo electric immunobiosensor for foot and mouth disease virus typing.
    Gajendragad MR; Kamath KN; Anil PY; Prabhudas K; Natarajan C
    Vet Microbiol; 2001 Feb; 78(4):319-30. PubMed ID: 11182498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Butchaiah G; Rao BU
    Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies.
    Gomes P; Giralt E; Andreu D
    J Immunol Methods; 2000 Feb; 235(1-2):101-11. PubMed ID: 10675762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera.
    Alonso A; Martins MA; Gomes Mda P; Allende R; Söndahl MS
    J Vet Diagn Invest; 1992 Jul; 4(3):249-53. PubMed ID: 1325192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody.
    McCullough KC; Crowther JR; Butcher RN
    J Immunol Methods; 1985 Sep; 82(1):91-100. PubMed ID: 2993421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structure and antigenicity of a type C foot-and-mouth disease virus.
    Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
    Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application.
    Hamblin C; Barnett IT; Crowther JR
    J Immunol Methods; 1986 Oct; 93(1):123-9. PubMed ID: 3021855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of serological and biochemical methods for strain differentiation of foot-and-mouth disease type A viruses.
    Armstrong RM; Samuel AR; Carpenter WC; Kant R; Knowles NJ
    Vet Microbiol; 1994 Apr; 39(3-4):285-98. PubMed ID: 8042276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.
    Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.